Antibody recognizing human Leukemia Inhibitory Factor (LIF) and use of antiLIF antibodies in the treatment of diseases associated with unwanted cell proliferation

Details for Australian Patent Application No. 2011237922 (hide)

Owner Fundacio Privada Institut D'Investigacio Oncologica Vall D'Hebron Fundacio Privada Institucio Catalana De Recerca I Estudis Avancats (ICREA)

Inventors Suarez, Joan Seoane; Folgueira, Judit Anido; Borderias, Andrea Saez

Agent Shelston IP

Pub. Number AU-A-2011237922

PCT Pub. Number WO2011/124566

Priority 10380049.6 05.04.10 EP

Filing date 5 April 2011

Wipo publication date 13 October 2011

International Classifications

C07K 16/24 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

1 November 2012 PCT application entered the National Phase

  PCT publication WO2011/124566 Priority application(s): WO2011/124566

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011237936-Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use

2011237901-Hemostatic sponge